Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Segovia-Cubero, Javier
85  Ergebnisse:
OpenAccess-Volltexte X
?
1

Prevalence, characteristics and prognostic impact of aortic..:

Shahim, Bahira ; Shahim, Angiza ; Adamo, Marianna...
https://doi.org/10.1002/ejhf.2908.  , 2023
Link: http://hdl.handle.net/21..
 
?
2

β3 adrenergic agonist treatment in chronic pulmonary hypert..:

García-Álvarez, Ana ; Blanco, Isabel ; García-Lunar, Inés...
Instituto de Salud Carlos III INT19/00022.  , 2023
Link: https://ddd.uab.cat/reco..
 
?
3

β3 adrenergic agonist treatment in chronic pulmonary hypert..:

García-Álvarez, Ana ; Blanco, Isabel ; García-Lunar, Inés...
10.1002/ejhf.2745.  , 2023
Link: https://hdl.handle.net/2..
 
?
4

Danon Disease Presenting as Eosinophilic Myocarditis: Key R..:

Angulo-Lara, Basilio ; Garrido-González, Ramón ; Salas Antón, Clara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107000/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biom..:

Jiménez-Blanco Bravo, Marta ; Pérez-Gómez, Laura ; Hernández-Pérez, Francisco J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019134/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Pat..:

Delgado-Jiménez, Juan F ; Segovia-Cubero, Javier ; Almenar-Bonet, Luis...
2077-0383.  , 2022
Link: http://hdl.handle.net/10..
 
?
7

Gender Differences in Cardiogenic Shock Patients: Clinical ..:

Lozano-Jiménez, Sara ; Iranzo-Valero, Reyes ; Segovia-Cubero, Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326060/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Pat..:

Delgado-Jiménez, Juan F ; Segovia-Cubero, Javier ; Almenar-Bonet, Luis...
https://doi.org/10.3390/jcm11051170.  , 2022
Link: http://hdl.handle.net/21..
 
?
9

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Pat..:

Delgado-Jiménez, Juan F ; Segovia-Cubero, Javier ; Almenar-Bonet, Luis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910891/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Persistent Pulmonary Hypertension in Corrected Valvular Hea..:

Bermejo, Javier ; González-Mansilla, Ana ; Mombiela, Teresa...
http://hdl.handle.net/10668/16919.  , 2021
Link: http://hdl.handle.net/10..
 
?
11

Persistent Pulmonary Hypertension in Corrected Valvular Hea..:

Bermejo, Javier ; González‐Mansilla, Ana ; Mombiela, Teresa...
https://doi.org/10.1161/JAHA.120.019949.  , 2021
Link: http://hdl.handle.net/21..
 
?
12

Persistent Pulmonary Hypertension in Corrected Valvular Hea..:

Bermejo, Javier ; González-Mansilla, Ana ; Mombiela, Teresa...
https://doi.org/10.1161/JAHA.120.019949.  , 2021
Link: https://hdl.handle.net/2..
 
?
13

Design of the b3-adrenergic agonist treatment in chronic pu..:

Garcia-Lunar, Inés ; Blanco, Isabel ; Fernández-Friera, Leticia...
JACC. Basic to Translational Science.  , 2021
Link: http://hdl.handle.net/10..
 
?
14

Persistent pulmonary hypertension in corrected valvular hea..:

Bermejo, Javier ; González-Mansilla, Ana ; Mombiela, Teresa...
European Commission EC07/90772.  , 2021
Link: https://ddd.uab.cat/reco..
 
?
15

A 3-biomarker 2-point-based risk stratification strategy in..:

Álvarez-García, Jesús ; García-Osuna, Álvaro ; Vives-Borrás, Miquel...
https://doi.org/10.3389/fphys.2021.708890.  , 2021
Link: http://hdl.handle.net/21..
 
1-15